Ocular Therapeutix, Inc. (OCUL) stock analysis and AI prediction
The company facts of Ocular Therapeutix, Inc., with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Ocular Therapeutix, Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $1.3 billion
- Size
- Small cap
- Employees
- 325
- Headquarters
- BEDFORD, MA
- Listed since
- July 25, 2014
- Website
- ocutx.com
More Healthcare stocks
Other small cap stocks
Keep going
OCUL questions
What is the AI prediction for OCUL stock?
Each market day our model rates Ocular Therapeutix, Inc. (OCUL) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the OCUL prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for OCUL?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see OCUL options?
The OCUL options page explains its calls, puts and Greeks. The full OCUL options chain, every strike and expiry, is in the OpPreds app.